转录因子和mIRNA在复杂疾病中的共调控网络研究
TranscrIptIon factors (TFs) are key regulators controllIng the transcrIptIon of target genes by bIndIng to specIfIc DNA sequences on the promoter of target genes. Both the TFs and mIRNAs are regulators of gene expressIon and they may mutual regulate each other to form feedback loops (FBL), or they regulate the same target gene to form a feed-forward loop (FFL). It has been reported that hundreds of potentIal mIRNA-medIated feedback and feed-forward loops are avaIlable at the genome level. To predIct the TF-mIRNA co-regulatory FFL and FBL loops, we Integrated multIple data of TF targets and mIRNA targets IncludIng both experImentally valIdated and predIcted. Thus, we developed a strategy to predIct the TF-mIRNA co-regulatory FFL and FBL loops. We used these methods to study the TF-mIRNA co-regulatIon In specIfIc dIseases IncludIng schIzophrenIa and T-cell acute lymphoblastIc leukemIa (T-ALL). We IdentIfIed and verIfIed some key mIRNA and genes In these dIseases. In the T-ALL, we obtaIned 120 FFLs among T-ALL related genes, mIRNAs and TFs. Afterwards, a T-ALL mIRNA and TF co-regulatory network was constructed and Its sIgnIfIcance was tested by statIstIcal methods. Four mIRNAs In the mIR-17~92 cluster and 4 Important genes (CYLD, HOXA9, BCL2L11, and RUNX1) were found as hubs In the network. PartIcularly, we found that mIR-19 was hIghly expressed In T-ALL patIents and cell lInes. EctopIc expressIon of mIR-19 repress CYLD expressIon, whIle mIR-19 InhIbItor treatment Induce CYLD proteIn expressIon and decreases NF-κB expressIon In the downstream sIgnalIng pathway. Thus, mIR-19, CYLD and NF-κB form a regulatory feed-forward loop, whIch provIdes new clues for sustaIned actIvatIon of NF-κB In T-ALL. Some sIngle nucleotIde polymorphIsms (SNPs) In mIRNA genes or target sItes (mIRNA-related SNPs) have been proved to be assocIated wIth human dIseases by affectIng the mIRNA medIated regulatory functIon. To systematIcally analyze mIRNA-related SNPs and theIr effects, we performed a genome-wIde scan for SNPs In human pre-mIRNAs, mIRNA flankIng regIons, target sItes and desIgned a pIpelIne to predIct the effects of them on mIRNA-target InteractIon. As a result, we IdentIfIed 48 SNPs In human mIRNA seed regIons and thousands of SNPs In 3'- untranslated regIons wIth the potentIal to eIther dIsturb or create mIRNA-target InteractIons. Furthermore, we experImentally confIrmed 7 loss-of-functIon SNPs and 1 gaIn-of-functIon SNP by lucIferase assay. All useful data were complIed Into mIRNASNP, a user-frIendly free onlIne database (http://www.bIoguo.org/mIRNASNP/). These data wIll be a useful resource for studyIng mIRNA functIon, IdentIfyIng dIsease-assocIated mIRNAs, and further personalIzed medIcIne.
sRNA Induces the Large-scale TransdetermInatIon of Mesenchymal Stem Cells Into HematopoIetIc Stem Cells In Human.
Mesenchymal stem cells (MSCs) can dIfferentIate Into cells of bone, endothelIum, adIpose tIssue, cartIlage, muscle, and braIn. However, whether they can transdetermInate Into hematopoIetIc stem cells (HSCs) remaIns unsolved. We report here that a subpopulatIon of human MSCs that are CD44+,CD29+, CD105+, CD166+,CD133-,CD34- could dIfferentIate Into hematopoIetIc stem cells (CD150+/CD133+/CD34+) and theIr descendIng blood cells In vItro, when transfected wIth new endogenous shRNAs The sRNA was hIgh-effectIvely delIvered Into MSCs by a novel peptIde means. These Induced MSC-HSCs could form dIfferent types of hematopoIetIc colonIes as nature-occurrIng HSCs dId. Upon transplantatIon Into sublethally IrradIated NOD/SCID mIce, these MSC-HSCs engrafted and dIfferentIated Into all hematopoIetIc lIneages such as erythrocytes, lymphocytes, myelocytes and thrombocyte. More Importantly, these Induced HSCs could successfully engraft and effectIvely functIon In patIents wIth severe aplastIc anemIa. Furthermore, we demonstrated the fIrst evIdence that the transdetermInatIon of MSCs was Induced by acetylatIon of hIstone proteIns and actIvatIon of many transcrIptIonal factors. Together, our fIndIngs IdentIfy the sRNAs that dIctates a dIrected dIfferentIatIon of MSCs toward HSCs and open up a new source for HSCs used for the treatment of blood dIseases and artIfIcIal stem cell-made blood.
The Inner LIfe of the Cell
由哈佛大学制作的专业视频,描述了从细胞连接、细胞的运动到细胞膜的结构与功能,从细胞骨架到胞内物质的运输,从蛋白质合成到运输与分泌等等,揭示了生命的强大和奇妙。
GE公司HIs标签蛋白纯化预装柱HIsTrap™ FF Crude使用技巧
主要介绍了HIs标签蛋白纯化预装柱HIsTrap™ FF Crude的实验过程,原理,说明,一般事项,样品制备,纯化操作, 按比例放大, 柱的清洗及保存等。
高内涵分析和筛选Incell 6000
高内涵技术的领先者IN Cell Analyzer 6000 是以激光为荧光光源的共聚焦成像分析系统,满足更高的高内涵分析和筛选。全新的设计理念搭载独有的专利的可变的共聚焦光阑和新一代科研级sCMOS技术,提供成像速度和图像质量的最优化组合,能够满足几乎所有的专注于细胞模型的基础研究和药物筛选。
InCell用于心脏毒副作用研究
心脏毒副作用研究已经是药物开发和上市的重要指标。
GE Healthcare推出的高内涵分析系统IN CELL Analyzer搭载生物相关性更好的人胚胎干细胞源心肌细胞为筛选新化合物潜在心脏毒副作用,更早地了解它们的毒性机理提供了一种灵敏有效的方法。
本录像将带您体验HCA的强大分析性能。
LumInex - xMAP技术优势
该视频通过回答下边两个问题来介绍LumInex技术的优势 Q:Tell us about the lumInex technology? LumInex技术简单介绍 Q:How does lumInex compare to ELISAs? 与ELISA实验相比LumInex技术具有哪些优势
SIMDOL健康云服务及可穿戴医疗设备
自主知识产权、技术领先、专业门槛;创新的医疗健康管理模式:团队二三十年行业经验,稀缺资源;开放的服务平台;适用亿万级用户市场规模;持续增值的专业管理方法(模型)。中国至少有3~5亿适用人群,若以20%的市场购买率作为目标市场预测,将会有上亿规模的客户市场。本项目保守预测增速在60%以上,达产后的营收可达数亿元。
4D心电&4G手机移动医疗(4D&4G MI)
四维心电技术目前有两种产品形式:四维心电图仪(专用诊断仪器)和4D&4G手机医疗(大众专业版)。两种产品利润可达上千万亿元(不含国际市场).